# Peptron delays new plant investment completion to H1 2027, increases budget to 89 billion won

Peptron announced a delay in the completion of its new cGMP-grade sustained-release drug production facility investment from December 2026 to June 2027, and an increase in investment amount from 65 billion won to 89 billion won.

- Type: Investment
- Announced: 2025-12-03
- Where: Daejeon, South Korea
- Value: $67.0M (89.0B KRW)
- Starts operating: 30 Jun 2027
- Status: announced
- Capacity: 10 million vials of sustained-release drugs
- Products: sustained-release drugs
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Peptron](https://endata.com/companies/88869.md)

## Sources

- [marketin.edaily.co.kr](https://marketin.edaily.co.kr/News/ReadE?newsId=04913446642394912), 2025-12-03: "신공장 투자 종료일이 2026년 말에서 2027년 상반기 말로 지연됐다"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.